0001209191-21-048540.txt : 20210729 0001209191-21-048540.hdr.sgml : 20210729 20210729171706 ACCESSION NUMBER: 0001209191-21-048540 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210728 FILED AS OF DATE: 20210729 DATE AS OF CHANGE: 20210729 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Collins Helen Louise CENTRAL INDEX KEY: 0001701247 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37620 FILM NUMBER: 211128601 MAIL ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kura Oncology, Inc. CENTRAL INDEX KEY: 0001422143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 611547851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 500-8800 MAIL ADDRESS: STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: ZETA ACQUISITION CORP III DATE OF NAME CHANGE: 20071227 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-07-28 0 0001422143 Kura Oncology, Inc. KURA 0001701247 Collins Helen Louise C/O KURA ONCOLOGY, INC. 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 1 0 0 0 Option to purchase common stock 18.98 2021-07-28 4 A 0 46000 0.00 A 2031-07-27 Common Stock 46000 46000 D Option to purchase common stock 18.98 2021-07-28 4 A 0 19166 0.00 A 2031-07-27 Common Stock 19166 19166 D This option vests in three equal annual installments commencing on the one year anniversary of the date of grant. This option vests in full on the one year anniversary of the date of grant. Marc Grasso, Attorney-in-fact for Helen Collins 2021-07-29